Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Trospium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,252Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BMS taps Taye Diggs for schizophrenia educational campaign
    BMS taps Taye Diggs for schizophrenia educational campaign

    22 May 2024

    // Andrea Park FIERCE PHARMA

    https://www.fiercepharma.com/marketing/bms-taps-taye-diggs-its-best-man-schizophrenia-educational-campaign

    Andrea Park FIERCE PHARMA
    22 May 2024
    Share Share
    Karuna’s schizophrenia drug succeeds in a second late-stage trial
    Karuna’s schizophrenia drug succeeds in a second late-stage trial

    21 Mar 2023

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/karuna-schizophrenia-emergent-3-trial-karxt/645392/#:~:text=The%20results%20add%20to%20a,living%20with%20the%20brain%20disorder.&text=An%20experimental%20drug%20from%20Karuna,a%20potential%20therapy%20for%20schizophrenia.

    BIOPHARMADIVE
    21 Mar 2023
    Share Share
    Segal Trials Participation in Study Shows Results From Phase 3 EMERGENT-2 KarXT
    Segal Trials Participation in Study Shows Results From Phase 3 EMERGENT-2 KarXT

    23 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220822005631/en

    BUSINESSWIRE
    23 Aug 2022
    Share Share
    Karuna announces positive results from Phase III trial into schizophrenia
    Karuna announces positive results from Phase III trial into schizophrenia

    10 Aug 2022

    // PHARMA FILE

    http://www.pharmafile.com/news/722654/karuna-therapeutics-announces-positive-results-phase-iii-trial-schizophrenia

    PHARMA FILE
    10 Aug 2022
    Share Share
    Zai Partner Karuna Announces Results from PIII EMERGENT-2 Trial of KarXT
    Zai Partner Karuna Announces Results from PIII EMERGENT-2 Trial of KarXT

    08 Aug 2022

    // PRESS RELEASE

    https://ir.zailaboratory.com/news-releases/news-release-details/zai-lab-partner-karuna-therapeutics-announces-positive-results

    PRESS RELEASE
    08 Aug 2022
    Share Share
    Granules India gets USFDA nod for overactive bladder treatment capsule
    Granules India gets USFDA nod for overactive bladder treatment capsule

    23 Apr 2020

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-india-gets-usfda-nod-for-overactive-bladder-treatment-capsule/articleshow/75344959.cms

    ECONOMIC TIMES
    23 Apr 2020
    Share Share